US Markets Closed

AI-assisted · Not financial adviceNot advice

AI-assisted · Not financial advice.

US Markets Closed

AI-assisted · Not financial adviceNot advice

US Markets Closed

AI-assisted · Not financial adviceNot advice

$COCP

Name: COCP (Cocrystal Pharma) — Market Sentiment & Discussion
Creator: MarketMind
License: https://stockmarketsentimentai.com/methodology

Cocrystal Pharma· 4/3/2026, 11:57:35 AM

Data Checks· 1 of 1 passed

Insiders (90d)

2 buys, 0 sells

Last: BUY Feb 24· 38d ago

▲Net buying $67K

Reddit: Mixed · DivergentAttention: Surging

Community Take (7D)

Bullish sentiment on COCP recovery to $2 due to FDA fast-track news and increasing volume.

Key Events:

Apr 2:Commenters express optimism about COCP reaching $2 soon, citing increased trading volume and recent FDA fast-track designation.bullish
Apr 3:Investors continue to hold or buy more COCP, hoping for a price increase past $1.8, reflecting confidence in the stock's potential.bullish

Sentiment: 80% bullish (early) → 85% bullish (late)

Impact: Initial excitement over FDA news led to sustained optimism as trading volume increased, reinforcing bullish sentiment.

Risks: Market volatility, Regulatory changes

News vs Reddit

Smart Money

News Signal

News Outlets · Analyst Coverage

bullish

Signal Quality75%

Reddit Sentiment

Reddit · Community Discussion

neutral

Confidence Level10%

The Story

News Summary

FDA Fast Track for Norovirus Treatment

Key Events

Mar 31:Phase 1b norovirus challenge study underway.
Apr 2:FDA grants Fast Track designation for CDI-988.

Sentiment: 60% bullish / 40% neutral (early) → 90% bullish / 10% neutral (late)

Impact: The focus shifted from the initiation of clinical studies to the significant regulatory milestone of Fast Track designation, enhancing the company's prospects.

Analyst ConsensusBuy (1 analysts)

1 Buy · 0 Hold · 0 Sell

Signal

Bullish

Confidence

75%

Based on curated news sources (not retail comments)

Over the last 7 days: The Fast Track designation for CDI-988 highlights significant progress in addressing an unmet medical need.

SentimentCautious Optimism

AnalysisHype

Bullish Factors

✓FDA granted Fast Track designation to CDI-988, facilitating accelerated development for norovirus treatment.

Risk Factors

No bear risks identified

Analyze with AI yahoo!finance Reddit Answers

AI-assisted · Not financial advice.

$COCP - Cocrystal Pharma | MarketMind | MarketMind

$COCP

Cocrystal Pharma· 4/3/2026, 11:57:35 AM

Data Checks· 1 of 1 passed

Insiders (90d)

2 buys, 0 sells

Last: BUY Feb 24· 38d ago

▲Net buying $67K

Reddit: Mixed · DivergentAttention: Surging

Community Take (7D)

Bullish sentiment on COCP recovery to $2 due to FDA fast-track news and increasing volume.

Key Events:

Apr 2:Commenters express optimism about COCP reaching $2 soon, citing increased trading volume and recent FDA fast-track designation.bullish
Apr 3:Investors continue to hold or buy more COCP, hoping for a price increase past $1.8, reflecting confidence in the stock's potential.bullish

Sentiment: 80% bullish (early) → 85% bullish (late)

Impact: Initial excitement over FDA news led to sustained optimism as trading volume increased, reinforcing bullish sentiment.

Risks: Market volatility, Regulatory changes

News vs Reddit

Smart Money

News Signal

News Outlets · Analyst Coverage

bullish

Signal Quality75%

Reddit Sentiment

Reddit · Community Discussion

neutral

Confidence Level10%

The Story

News Summary

FDA Fast Track for Norovirus Treatment

Key Events

Mar 31:Phase 1b norovirus challenge study underway.
Apr 2:FDA grants Fast Track designation for CDI-988.

Sentiment: 60% bullish / 40% neutral (early) → 90% bullish / 10% neutral (late)

Impact: The focus shifted from the initiation of clinical studies to the significant regulatory milestone of Fast Track designation, enhancing the company's prospects.

Analyst ConsensusBuy (1 analysts)

1 Buy · 0 Hold · 0 Sell

Signal

Bullish

Confidence

75%

Based on curated news sources (not retail comments)

Over the last 7 days: The Fast Track designation for CDI-988 highlights significant progress in addressing an unmet medical need.

SentimentCautious Optimism

AnalysisHype

Bullish Factors

✓FDA granted Fast Track designation to CDI-988, facilitating accelerated development for norovirus treatment.

Risk Factors

No bear risks identified

Analyze with AI yahoo!finance Reddit Answers